脑部放疗，上午比下午敏感许多！
) H0 L$ d3 V% F8 L; a8 t' O: B6 H
1 x" {8 L% D6 K
! m a$ \ M# N5 V) p! e1 SCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
2 q8 A5 P$ c7 U) ~9 }" t4 b- KGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?4 B7 }1 ?+ C8 R% ^
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.5 N0 O' N) ^5 C* h4 }: Q, ^
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.7 o% d3 e7 ?0 u" h. o8 V# O8 F! m
F, h. ]3 G: P% Q7 s+ d/ D
Abstract: ?2 N, E2 S" Q+ R0 t* \
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
+ f3 _: }/ M8 P) ]- J. i+ g) G( E: \" I' c9 \8 i
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.1 A# m& ~: i0 K% a7 E# J! m
3 C% n# W/ E4 R7 W
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).; h# `' X7 W! @3 ^$ b
$ }- P) T3 f, J& O) YCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
# S+ \- s1 x2 h3 e3 G9 z
, l! p$ e; y# N8 S: i! ?. B# m |
显身卡
